Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma

• Main Authors: Xiaoliang Li (Author), Mingyan Zhou (Author), Weijia Chen (Author), Jiangbo Sun (Author), Yihang Zhao (Author), Gaoan Wang (Author), Bingshu Wang (Author), Yipeng Pan (Author), Junqing Zhang (Author), Jian Xu (Author)
• Format: Book
• Published: BMC, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Galangin, a flavonoid compound, is derived from Alpinia officinarum Hance. Previous studies have shown that galangin can inhibit the proliferation of hepatocellular carcinoma (HCC), but its mechanism is still unclear. This study aims to investigate the potential targets and molec...